Stereotactic and Functional Neurosurgery 1997-01-01

gamma-Amino-beta-hydroxybutyric acid as add-on therapy in adult patients with severe focal epilepsy.

E García-Flores, R Farías

Index: Stereotact. Funct. Neurosurg. 69(1-4 Pt 2) , 243-6, (1997)

Full Text: HTML

Abstract

Total seizure frequency was evaluated among adult patients with severe partial epilepsy refractory to medical treatment. Clinical status was assessed before, and after a synthetic analog of gamma-amino-beta-hydroxybutyric acid (GABOB) was used as add-on therapy. Twenty-five patients with temporal and frontal lobe epilepsy were included in the trial. They received GABOB 250 mg twice daily during a 26-week period. Concentrations of concomitant antiepileptic medication were not modified. Twenty-five percent of the patients showed a 50% reduction of the total seizure frequency. There were no serious adverse effects related to medication.

Related Compounds

Related Articles:

Enantioselective actions of 4-amino-3-hydroxybutanoic acid and (3-amino-2-hydroxypropyl)methylphosphinic acid at recombinant GABA(C) receptors.

2008-01-01

[Bioorg. Med. Chem. Lett. 18 , 402-4, (2008)]

GABA agonists. Resolution, absolute stereochemistry, and enantioselectivity of (S)-(+)- and (R)-(-)-dihydromuscimol.

1985-11-01

[J. Med. Chem. 28(11) , 1612-7, (1985)]

Formation of gamma-amino-beta-hydroxybutyric acid from 2-hydroxyputrescine in rat brain.

1988-08-01

[J. Neurochem. 51(2) , 548-51, (1988)]

Kynurenines do not antagonise GABA in rat hippocampus.

1986-08-22

[Eur. J. Pharmacol. 128(1-2) , 81-3, (1986)]

Dose-related effects of gamma-amino beta-hydroxy butyric acid (GABOB) infusion on growth hormone secretion in normal women.

1982-01-01

[J. Endocrinol. Invest. 5(2) , 101-6, (1982)]

More Articles...